A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles

Initial treatment of CLL: integrating biology and functional status

(2015) N. Jain et al.   BLOOD

Targeted therapies in CLL: mechanisms of resistance and strategies for management

(2015) J. A. Woyach et al.   BLOOD

State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines

(2014) Charlene M. Dawidczyk et al.   JOURNAL OF CONTROLLED RELEASE

Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice

(2014) P Macor et al.   LEUKEMIA

Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment

(2013) Michael Hallek   AMERICAN JOURNAL OF HEMATOLOGY

New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles

(2013) Nelly Mezzaroba et al.   PLoS One

Xenograft models of chronic lymphocytic leukemia: problems, pitfalls and future directions

(2012) M T S Bertilaccio et al.   LEUKEMIA

Nanoparticle Delivery of Cancer Drugs

(2011) Andrew Z. Wang et al.   Annual Review of Medicine

Principles and Current Strategies for Targeting Autophagy for Cancer Treatment

(2011) R. K. Amaravadi et al.   CLINICAL CANCER RESEARCH

The Lysosomotropic Agent, Hydroxychloroquine, Delivered in a Biodegradable Nanoparticle System, Overcomes Drug Resistance of B-Chronic Lymphocytic Leukemia Cells In Vitro

(2010) Eduardo Mansilla et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Interaction of the Retinoblastoma Protein with Orc1 and Its Recruitment to Human Origins of DNA Replication

(2010) Ramiro Mendoza-Maldonado et al.   PLoS One

Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells

(2009) Rayhana Rahim et al.   ANTI-CANCER DRUGS

P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma (Supplementry Material)

(2009) C. Tripodo et al.   CURRENT CANCER DRUG TARGETS

Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery

(2009) Deepa A. Rao et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Effects of the Antlered Form ofGanoderma lucidumon Tumor Growth and Metastasis in Cyclophosphamide-Treated Mice

(2008) Yuji NONAKA et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies

(2008) Paolo Macor et al.   CURRENT PHARMACEUTICAL DESIGN

Ocular Toxicity of Hydroxychloroquine

(2008) Rodney Tehrani et al.   Seminars in Ophthalmology